[1] |
Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-49.
|
[2] |
Li M,Gu J.Changing patterns of colorectal cancer in China over a period of 20 years[J].World JGastroenterol,2005,11(30):4685-8.
|
[3] |
Glynne-Jones R,Mathur P,Elton C,et al.The multidisciplinary management of gastrointestinalcancer.Multimodal treatment of rectal cancer[J].Best Pract Res Clin Gastroenterol,2007,21(6):1049-70.
|
[4] |
Sebag-Montefiore D,Bujko K,Valentini V.Rectal cancer multidisciplinary management:evidences andfuture landscape[J].Radiother Oncol,2009,92(2):145-7.
|
[5] |
Wille-Jrgensen P,Bülow S.The multidisciplinary team conference in rectal cancer--a stepforward[J].Colorectal Dis,2009,11(3):231-2.
|
[6] |
Bisceglia G,Mastrodonato N,Rucci B,et al.Effectiveness of neoadjuvant radiotherapy in thetreatment of locally advanced rectal cancer:a single-center experience in 263 patients[J].DigSurg,2010,27(3):217-23.
|
[7] |
Valentini V,Aristei C,Glimelius B,et al.Multidisciplinary Rectal Cancer Management:2nd EuropeanRectal Cancer Consensus Conference (EURECA-CC2)[J].Radiother Oncol,2009,92(2):148-63.
|
[8] |
Peeters KC,Marijnen CA,Nagtegaal ID,et al.The TME trial after a median follow-up of 6years:increased local control but no survival benefit in irradiated patients with resectable rectalcarcinoma[J].Ann Surg,2007,246(5):693-701.
|
[9] |
Bosset JF,Collette L,Calais G,et al.Chemotherapy with preoperative radiotherapy in rectal cancer[J].N Engl J Med,2006,355(11):1114-23.
|
[10] |
Sauer R,Becker H,Hohenberger W,et al.Preoperative versus postoperative chemoradiotherapy forrectal cancer[J].N Engl J Med,2004,351(17):1731-40.
|
[11] |
Sebag-Montefiore D,Stephens RJ,Steele R,et al.Preoperative radiotherapy versus selectivepostoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016):amulticentre,randomised trial[J].Lancet,2009,373(9666):811-20.
|
[12] |
Camma C,Giunta M,Fiorica F,et al.Preoperative radiotherapy for resectable rectal cancer:A meta-analysis[J].JAMA,2000,284(8):1008-15.
|
[13] |
Colorectal Cancer Collaborative Group.Adjuvant radiotherapy for rectal cancer:a systematicoverview of 8,507 patients from 22 randomised trials[J].Lancet,2001,358(9290):1291-304.
|
[14] |
Heald RJ,Ryall RD.Recurrence and survival after total mesorectal excision for rectal cancer[J].Lancet,1986,1(8496):1479-82.
|
[15] |
Galizia G,Lieto E,Ferraraccio F,et al.Determination of molecular marker expression can predictclinical outcome in colon carcinomas[J].Clin Cancer Res,2004,10(10):3490-9.
|
[16] |
Roskoski R Jr.Vascular endothelial growth factor (VEGF) signaling in tumor progression[J].Crit Rev Oncol Hematol,2007,62(3):179-213.
|
[17] |
Gupta VK,Jaskowiak NT,Beckett MA,et al.Vascular endothelial growth factor enhances endothelialcell survival and tumor radioresistance[J].Cancer J,2002,8(1):47-54.
|
[18] |
Gorski DH,Beckett MA,Jaskowiak NT,et al.Blockage of the vascular endothelial growth factorstress response increases the antitumor effects of ionizing radiation[J].Cancer Res,1999,59(14):3374-8.
|
[19] |
Nieder C,Wiedenmann N,Andratschke N,et al.Current status of angiogenesis inhibitors combinedwith radiation therapy[J].Cancer Treat Rev,2006,32(5):348-64.
|
[20] |
Giatromanolaki A,Sivridis E,Koukourakis MI.Angiogenesis in colorectal cancer:prognostic andtherapeutic implications[J].Am J Clin Oncol,2006,29(4):408-17.
|
[21] |
Giralt J,Navalpotro B,Hermosilla E,et al.Prognostic significance of vascular endothelial growthfactor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy[J].Oncology,2006,71(5-6):312-9.
|
[22] |
Nozue M,Isaka N,Fukao K.Over-expression of vascular endothelial growth factor afterpreoperative radiation therapy for rectal cancer[J].Oncol Rep,2001,8(6):1247-9.
|
[23] |
Yancopoulos GD,Davis S,Gale NW,et al.Vascular-specific growth factors and blood vesselformation[J].Nature,2000,407(6801):242-8.
|
[24] |
Winkler F,Kozin SV,Tong RT,et al.Kinetics of vascular normalization by VEGFR2 blockade governsbrain tumor response to radiation:role of oxygenation,angiopoietin-1,and matrix metalloproteinases[J].Cancer Cell,2004,6(6):553-63.
|
[25] |
Li J,Huang S,Armstrong EA,et al.Angiogenesis and radiation response modulation after vascularendothelial growth factor receptor-2 (VEGFR2) blockade[J].Int J Radiat Oncol Biol Phys,2005,62(5):1477-85.
|
[26] |
Kozin SV,Boucher Y,Hicklin DJ,et al.Vascular endothelial growth factor receptor-2-blockingantibody potentiates radiation-induced long-term control of human tumor xenografts[J].CancerRes,2001,61(1):39-44.
|
[27] |
Lee CG,Heijn M,di Tomaso E,et al.Anti-Vascular endothelial growth factor treatment augmentstumor radiation response under normoxic or hypoxic conditions[J].Cancer Res,2000,60(19):5565-70.
|